Kalamazoo-based RealBio Technology Inc. has received a $250,000 investment from the Biosciences Research and Commercialization Center as part of an ongoing commitment to growing early-stage companies in Michigan.
RealBio, located in the Southwest Michigan Innovation Center of Western Michigan University's Business Technology and Research Park, is commercializing cell technology that lets researchers study the growth and development of human primary cells and tissues over a long period of time. The initial market for the technology will be to generate a consistent supply of stem cells for research purposes, and the formation of tissues for in-vitro toxicology. (more info at http://www.realbiotechnology.com/ ). The work flows from research funded by a $5 million grant to Aastrom Biosciences from the Defense Advanced Research Projects Agency of the U.S. Defense Department.
"We are extremely pleased to have the support of the BRCC, and to have BRCC as an investor," says RealBio CEO Paul Neeb. "This investment recognizes the business- and job-creating potential of our revolutionary stem cell research technology."
RealBio's work is part of the burgeoning life science's industry in Southwest Michigan, supported by a $50 million limited partnership venture fund managed by Southwest Michigan First. The portfolio, assembled under SWMF as the Life Science Fund, features firms with viable technologies committed to establishing a presence in the region and help retain human capital.
No comments:
Post a Comment